Streptococcus pneumoniae respiratory tract infections

被引:36
|
作者
Klugman, KP
Feldman, C
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Dept Int Hlth, Atlanta, GA 30322 USA
[2] S African Inst Med Res, Sch Pathol, MRC, Wits Pneumococcal Dis Res Unit, Johannesburg, South Africa
[3] Univ Witwatersrand, ZA-2050 Johannesburg, South Africa
[4] Johannesburg Hosp, Dept Med, Div Pulmonol, Johannesburg, South Africa
[5] Univ Witwatersrand, Johannesburg, South Africa
关键词
D O I
10.1097/00001432-200104000-00011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This review describes recent contributions to our understanding of pneumococcal pneumonia, Two genes have been described that encode enzymes involved with the biosynthesis of muropeptides, These enzymes may be novel antibiotic targets. The clinical impact of increasing antibiotic resistance on the treatment of pneumonia is the particular focus of the review. As resistant strains are more commonly associated with severe infections in patients with underlying disease, the interpretation of an association of resistance with poor clinical outcome is complicated. Curr Opin Infect Dis 14:173-179. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:173 / 179
页数:7
相关论文
共 50 条
  • [1] Antibiotic resistance in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in respiratory tract infections in outpatients
    Henning, C
    Bengtsson, L
    Jorup, C
    Engquist, S
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1997, 29 (06) : 559 - 563
  • [2] Response to Streptococcus pneumoniae and Clinical Characteristics of Patients with Recurrent Respiratory Tract Infections
    Patterson, A. M.
    Nelson, L. A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB8 - AB8
  • [3] Fluoroquinolones as treatment for patients with lower respiratory tract infections caused by Streptococcus pneumoniae
    Amyes, SGB
    Thomson, CJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (03) : 398 - 399
  • [4] Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults
    Korsgaard, J
    Moller, JK
    Kilian, M
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2005, 9 (05) : 274 - 279
  • [5] Efficacy of gemifloxacin against experimental respiratory tract infections in rats caused by Streptococcus pneumoniae
    Woodnutt, G
    Berry, V
    Page, R
    Singley, C
    Satterfield, J
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 : 38 - 38
  • [6] Intrapulmonary concentrations of telithromycin:: Clinical implications for respiratory tract infections due to Streptococcus pneumoniae
    Ong, CT
    Dandekar, PK
    Sutherland, C
    Nightingale, CH
    Nicolau, DP
    CHEMOTHERAPY, 2005, 51 (06) : 339 - 346
  • [7] Resistance phenotypes of Streptococcus pneumoniae and clinical outcome of respiratory tract infections treated with gemifloxacin
    Morrissey, I
    File, T
    Mandell, L
    Tillotson, GS
    CHEST, 2005, 128 (04) : 371S - 372S
  • [8] Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections
    Furuno, JP
    Metlay, JP
    Harnett, JP
    Wilson, J
    Langenberg, P
    McGregor, JC
    Zhu, JK
    Perencevich, EN
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (01) : 1 - 9
  • [9] Antimicrobial susceptibility of Streptococcus pneumoniae isolated from lower respiratory tract infections -: Therapeutic consequences
    Popescu, C.
    Popescu, G. A.
    Benea, E.
    Popoiu, M.
    Ivan, M.
    Gavriliu, L.
    Paise, A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S624 - S624
  • [10] Molecular Epidemiology of Streptococcus pneumoniae Isolates from Children with Recurrent Upper Respiratory Tract Infections
    Korona-Glowniak, Izabela
    Maj, Maciej
    Siwiec, Radoslaw
    Niedzielski, Artur
    Malm, Anna
    PLOS ONE, 2016, 11 (07):